Endoplasmic reticulum stress in innate immune cells - a significant contribution to non-alcoholic fatty liver disease

被引:9
|
作者
Zhou, Liangliang [1 ,2 ]
Shen, Haiyuan [1 ,2 ]
Li, Xiaofeng [2 ,3 ]
Wang, Hua [1 ,2 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Peoples R China
[2] Anhui Med Univ, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei, Peoples R China
[3] Anhui Med Univ, Anhui Inst Innovat Drugs, Sch Pharm, Hefei, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
non-alcoholic fatty liver disease; immune cells; unfolded protein response; endoplasmic reticulum stress; hepatic steatosis; UNFOLDED-PROTEIN-RESPONSE; LIFE-STYLE MODIFICATION; KILLER T-CELLS; ER STRESS; DENDRITIC CELLS; TRANSCRIPTION FACTOR; LIPID-METABOLISM; MACROPHAGE APOPTOSIS; DEFICIENCY PROTECTS; HEPATIC STEATOSIS;
D O I
10.3389/fimmu.2022.951406
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Liver disease and its complications affect millions of people worldwide. NAFLD (non-alcoholic fatty liver disease) is the liver disease associated with metabolic dysfunction and consists of four stages: steatosis with or without mild inflammation (NAFLD), non-alcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. With increased necroinflammation and progression of liver fibrosis, NAFLD may progress to cirrhosis or even hepatocellular carcinoma. Although the underlying mechanisms have not been clearly elucidated in detail, what is clear is that complex immune responses are involved in the pathogenesis of NASH, activation of the innate immune system is critically involved in triggering and amplifying hepatic inflammation and fibrosis in NAFLD/NASH. Additionally, disruption of endoplasmic reticulum (ER) homeostasis in cells, also known as ER stress, triggers the unfolded protein response (UPR) which has been shown to be involved to inflammation and apoptosis. To further develop the prevention and treatment of NAFLD/NASH, it is imperative to clarify the relationship between NAFLD/NASH and innate immune cells and ER stress. As such, this review focuses on innate immune cells and their ER stress in the occurrence of NAFLD and the progression of cirrhosis.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Hepatokines and non-alcoholic fatty liver disease
    Lebensztejn, Dariusz M.
    Flisiak-Jackiewicz, Marta
    Bialokoz-Kalinowska, Irena
    Bobrus-Chociej, Anna
    Kowalska, Irina
    ACTA BIOCHIMICA POLONICA, 2016, 63 (03) : 459 - 467
  • [42] Epidemiology of Non-Alcoholic Fatty Liver Disease
    Bellentani, Stefano
    Scaglioni, Federica
    Marino, Mariano
    Bedogni, Giorgio
    DIGESTIVE DISEASES, 2010, 28 (01) : 155 - 161
  • [43] PEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE
    Delvin, Edgard
    Patey, Natasha
    Dubois, Josee
    Henderson, Melanie
    Levy, Emile
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2015, 34 (01) : 3 - 12
  • [44] Non-alcoholic fatty liver disease and lipotoxicity
    Wasilewska, Natalia
    Lebensztejn, Dariusz Marek
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (01) : 1 - 6
  • [45] Autophagy and Non-Alcoholic Fatty Liver Disease
    Lavallard, Vanessa J.
    Gual, Philippe
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [46] Endoplasmic Reticulum Stress Response in Non-alcoholic Steatohepatitis: The Possible Role of Physical Exercise
    Passos, Emanuel
    Ascensao, Antonio
    Martins, Maria Joao
    Magalhaes, Jose
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (07): : 780 - 792
  • [47] Lipidomics in non-alcoholic fatty liver disease
    Kartsoli, Sofia
    Kostara, Christina E.
    Tsimihodimos, Vasilis
    Bairaktari, Eleni T.
    Christodoulou, Dimitrios K.
    WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (08) : 436 - 450
  • [48] Hypogonadism and non-alcoholic fatty liver disease
    Mintziori, Gesthimani
    Poulakos, Pavlos
    Tsametis, Christos
    Goulis, Dimitrios G.
    MINERVA ENDOCRINOLOGICA, 2017, 42 (02) : 145 - 150
  • [49] Management of non-alcoholic fatty liver disease
    Petroni, Maria Letizia
    Brodosi, Lucia
    Bugianesi, Elisabetta
    Marchesini, Giulio
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [50] Psoriasis and non-alcoholic fatty liver disease
    Wenk, K. S.
    Arrington, K. C.
    Ehrlich, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (04) : 383 - 391